$SWKS

Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more

Skyworks Solutions (SWKS) and Qorvo (QRVO) rose 10% and 7% respectively, recovering from prior sell-offs. Axon (AXON) fell 9% after a $1B convertible note sale. Revvity (RVTY) jumped 7% to a 52-week high, citing strong backlog. Dave & Buster's (PLAY) dropped 17% after missing Q2 revenue and EBITDA estimates. Enova (ENVA) tumbled 25% after withdrawing a regulatory application. Sysco (SYY) slid 3% on a 12.3M share offering. Alignment Healthcare (ALHC) fell 18% due to business headwinds. Waystar (W

Original reporting
Published Sep 15, 2026, 5:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 5:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more — source image
Decision brief

The 30-second read

$SWKSBullishLow
01

Why it matters

The article provides a snapshot of intraday sentiment shifts without new fundamental data for most companies, limiting actionable insight.

02

Market read

Shows sector‑wide volatility; useful for short‑term traders monitoring momentum.

03

What to watch

Liquidity constraints and short‑covering dynamics could drive short‑term reversals.

Relevance 5/10Novelty 4/10Timing: midday today

Background

Midday market roundup of the biggest price movers, covering chipmakers, consumer, fintech, and crypto‑related stocks.

Company-level read

Ticker impact

$SWKSBullishMedium confidence
Context

Skyworks Solutions shares jumped 10% midday, marking the largest move among chipmakers.

Expected impact

Potential continuation if momentum holds; watch for pullback near resistance.

Evidence & confidence

10% move is large for a mid‑cap; no new fundamental catalyst disclosed, so price action may be short‑term.

$QRVOBullishMedium confidence
Context

Qorvo advanced 7% after recovering from prior session's sell‑off.

Expected impact

May test prior highs; monitor volume for confirmation.

Evidence & confidence

Move reflects market sentiment shift rather than new company news.

$AXONBearishMedium confidence
Context

Axon Enterprise shares slid 9% after announcing $1 billion convertible senior note sale.

Expected impact

Further downside possible if additional financing is announced.

Evidence & confidence

Convertible note sale is a fresh financing event affecting valuation.

$RVTYBullishMedium confidence
Context

Revvity jumped 7% to a 52‑week high after leadership outlined a strong backlog at a Baird conference.

Expected impact

May sustain higher levels; watch for earnings follow‑up.

Evidence & confidence

Guidance details constitute new material for the stock.

$PLAYBearishHigh confidence
Context

Dave & Buster's fell 17% after Q2 results missed revenue and earnings estimates.

Expected impact

Further pressure likely until guidance improves.

Evidence & confidence

Earnings miss with specific numbers is a primary catalyst.

$ENVABearishMedium confidence
Context

Enova International tumbled >25% after withdrawing its regulatory applications for the Grasshopper Bancorp acquisition.

Expected impact

Stock may stay depressed pending new strategic direction.

Evidence & confidence

Deal status change is a material event.

$SYYBearishLow confidence
Context

Sysco shares slid 3% after announcing a $81‑priced common stock offering of 12.3 million shares.

Expected impact

Limited downside unless additional capital raises follow.

Evidence & confidence

Offering size is modest relative to market cap.

$ALHCBearishLow confidence
Context

Alignment Healthcare shares tanked 18% after citing headwinds in its skilled‑nursing business.

Expected impact

Potential rebound if guidance holds and issues resolve.

Evidence & confidence

Guidance unchanged tempers the negative impact.

Market effects

Highlights volatility in semiconductor, consumer discretionary, and crypto‑related sectors.

U.S. equity markets showed mixed reactions across sectors during midday trading.

Crypto regulatory news may influence global digital‑asset markets.

Counterpoint

Price moves may be over‑reactive; fundamentals remain unchanged for many names.

Key entities

  • Skyworks Solutions

    Semiconductor maker

  • Axon Enterprise

    Taser manufacturer

  • Coinbase

    Crypto exchange

Related articles

$COINHigh

The SEC Steps In to Ease Crypto’s Path After Big Legislative Loss

The SEC introduced a five-year exemption to securities laws to enable trading of tokenized stocks, following Congress' failure to pass the Clarity Act. This move aims to support digital assets and follows a 48-hour turnaround. Bitcoin and crypto-linked stocks like Coinbase (COIN), Robinhood (HOOD), and Circle (CRCL) saw gains.

$FLNCMed

Wall St rises as lower oil prices offset Fed rate hike

US stock indices rose on Thursday as lower oil prices offset the Fed's rate hike, with the S&P 500 up 0.94%. Tech shares like Nvidia and Amazon gained 2%. The Fed signaled more hikes may be needed, causing volatility. Crypto-linked stocks like Robinhood and Coinbase also rose. Fluence Energy fell 16% after lowering its 2026 revenue forecast.

$COINMed

Coinbase Retail Take Rates Look Unsustainable, Says Mizuho — Robinhood Competition Could Force Further Fee Cuts

Coinbase (COIN) lowered fees for active traders on Coinbase Advanced, prompting Mizuho to suggest this could signal broader pricing pressure. Mizuho reiterated a 'Neutral' rating and $155 price target, citing unsustainable retail take rates compared to Robinhood (HOOD). Coinbase's changes include lower fee tiers and combining spot and derivatives activity for volume tiers. Mizuho warns competitive pressure may extend to retail customers. COIN stock is down 29% YTD, while HOOD is down 6%.

$COINMedAI 8/10

Coinbase Has a Bitcoin Problem, and a Potentially Bigger Opportunity

Coinbase (COIN) reported Q2 2026 revenue of $1.22B, down 18.5% YoY, missing estimates. Bitcoin (BTC) trading volumes fell, but stablecoins and derivatives growth offers opportunities. 24/7 Wall St. sets a $212.94 price target, citing diversification. Shares are down 47.37% over a year but up 15.92% in the last month. Risks include declining transaction revenue and Bitcoin price volatility.

$AXONMedAI 8/10

Citizens reiterates Axon Enterprise stock rating amid ALPR scrutiny

Citizens reiterated a Market Outperform rating and $700 price target for Axon Enterprise (NASDAQ: AXON), citing its ALPR technology and competitive position. Axon shares are down 17% YTD but analysts expect 33% sales growth. Q2 earnings beat expectations with $1.88 EPS on $904.3M revenue, up 35% YoY. Axon plans a $1B convertible notes offering. Needham and William Blair maintained Buy/Outperform ratings.